These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 852245)
1. [Study of the efficacy of a beta-blocker, a nitrate derivative of their combination in 20 patients undergoing an exercise test]. Jullien G; Balansard P; Luccioni R; Gérard R Coeur Med Interne; 1977; 16(1):111-23. PubMed ID: 852245 [No Abstract] [Full Text] [Related]
2. [Ergometric study of the association of a beta-blocker and a nitrate derivative]. Jullien G Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951 [No Abstract] [Full Text] [Related]
3. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris. Dorow P; Schiess W Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704 [TBL] [Abstract][Full Text] [Related]
4. [Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)]. Bloch A; Horvat L Schweiz Rundsch Med Prax; 1974 Jan; 63(3):62-5. PubMed ID: 4605646 [No Abstract] [Full Text] [Related]
5. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease. Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603 [TBL] [Abstract][Full Text] [Related]
6. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study. Silber S; Vogler A; Theisen K Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414 [TBL] [Abstract][Full Text] [Related]
7. [Isosorbide dinitrate and bupranolol in the therapy of coronary heart disease (author's transl)]. Pascal N; Eggert R Arzneimittelforschung; 1978; 28(5):847-50. PubMed ID: 373775 [TBL] [Abstract][Full Text] [Related]
8. [Changes of the systolic variations of the left ventricle induced by isosorbitol dinitrate in patients with chronic coronary insufficiency]. Savioli RM; Del Nero E; Ortiz J; Rangel FA; Barretto AC; Papaléo Netto M; Diament J; Tranchesi J Arq Bras Cardiol; 1977 Dec; 30(6):441-4. PubMed ID: 614003 [No Abstract] [Full Text] [Related]
9. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function]. Vogler AC; Silber S; Vogel M; Theisen K Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761 [TBL] [Abstract][Full Text] [Related]
10. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy. Rosenfeld JB; Traub YM; Cohen L Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245 [No Abstract] [Full Text] [Related]
11. [Ergometric evaluation of the cardioprotective effect of pindolol in coronary disease. Comparison of 2 galenic forms]. Mérier GR; Perrenoud JJ Schweiz Med Wochenschr; 1988 Jul; 118(26):1016-20. PubMed ID: 3413461 [TBL] [Abstract][Full Text] [Related]
12. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease]. Ciopor M; Fischer A; Turina J; Hess OM Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502 [TBL] [Abstract][Full Text] [Related]
13. [Influence of digitalis on pindolol activity in exercise-induced cardiac failure in patients with coronary disease (author's transl)]. Oeff M; Beck OA; Hochrein H Dtsch Med Wochenschr; 1979 Jan; 104(3):98-103. PubMed ID: 759158 [TBL] [Abstract][Full Text] [Related]
14. [Clinical experiences with the Kö 1366 (Bunitrololhydrochloride) beta receptor blockader and the combination Kö 1366/Isosorbitdinitrate in patients with coronary disease]. Holzhey P Wien Med Wochenschr; 1975 Oct; 125(42-44):624-9. PubMed ID: 5819 [No Abstract] [Full Text] [Related]
15. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form]. Vogler AC; Silber S; Spiegelsberger F; Theisen K Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652 [TBL] [Abstract][Full Text] [Related]
16. [Isosorbide dinitrate in coronary heart disease. Effects of a delayed-action preparation during acute load and in chronic use]. Westermann KW; Eggert R; Kugler G; Priester G Med Klin; 1975 Aug; 70(35):1375-9. PubMed ID: 1177792 [TBL] [Abstract][Full Text] [Related]
17. [Effect of isosorbide dinitrate (sorbonit) on the exercise reaction in patients with coronary disease and in healthy individuals]. Zíołowski L; Wójcik-Ziółkowska E Pol Tyg Lek; 1989 Feb; 44(6):150-2. PubMed ID: 2813170 [TBL] [Abstract][Full Text] [Related]
18. The effects of chewable isosorbide dinitrate in coronary insufficiency. A report on exercise electrocardiograms in 13 patients. Gorman PA; Evans JM Med Ann Dist Columbia; 1971 Apr; 40(4):235-8. PubMed ID: 4995127 [No Abstract] [Full Text] [Related]